302 results
8-K
EX-2.2
XOMA
XOMA Corp
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:27am
and the Accountant, acting as agent of the Representative (on behalf of the Holders), to have access during normal business hours to the books
DEFA14A
XOMA
XOMA Corp
2 Apr 24
Additional proxy soliciting materials
7:40am
. You may view the proxy materials at www.ProxyVote.com or easily request a paper copy of the materials. We encourage you to access and review all
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
several strategic transactions. On December 5, Leerink provided certain representatives of Parent access to Kinnate’s data room and Parent and its … , Gibson Dunn & Crutcher (“Gibson Dunn”), with access to Kinnate’s electronic data room.
On February 2, 2024, representatives of Parent and Gibson Dunn
SC TO-T
EX-99
ounwwd4tuhs305
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-T
EX-99
9bjuqgan2ysg
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-T
EX-99
j9jm9j5 0d
4 Mar 24
Third party tender offer statement
5:24pm
8-K
EX-2.1
6ivv xminq4gre
16 Feb 24
XOMA Enters into Agreement to Acquire Kinnate Biopharma
9:08am
8-K
EX-4.3
gigq khracm0jvyyp2
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am
8-K
EX-4.2
gy6fz
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am
8-K
EX-4.1
q8ytbv9f e5d
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am
8-K
EX-99.1
nkso2
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am